Association between postoperative complications and recurrence-free survival in patients with hormone receptor-positive, HER2 negative breast cancer.
Among patients with stage I-III HR+/HER2- breast cancer, 30-day postoperative complications were not associated with RFS or OS, according to univariable analysis.